Sign in
Taking peopleNo phase

Vibrato device for removing blood clots in sudden pulmonary embolism

Tests a suction device to remove lung clots in adults with acute pulmonary embolism.

Key facts

Who runs it
Vicora, Inc.
Where
Poland2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Vibrato Aspiration System - Simple, Intuitive Approach to Clot Removal in Acute Pulmonary Embolism - a Safety & Feasibility Study
Status
Recruiting
People taking part
10 people, planned
Started
21 Aug 2026
Expected to end
Dec 2026
Type of study
Interventional
Treatments tested
  • Mechanical Thrombectomy
Record updated
25 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a sudden blood clot in the lungs (acute pulmonary embolism). It tests the Vibrato Aspiration System, a device that sucks the clot out.

Age
18 to 75 years
Sex
All sexes
Disease stage
Acute PE with symptoms for 14 days or less. A CT scan (CTA) shows a clot in at least one main or interlobar lung artery. The heart's right side is strained (RV/LV ratio of 0.9 or more). Blood pressure (systolic) is 90 mmHg or more, and heart rate is steady below 130 BPM. Doctors judge the person fit enough for the procedure.
Earlier treatment
No clot-dissolving drugs (thrombolytics) within 30 days before the baseline CT scan.
Biomarker or test result
RV/LV ratio of 0.9 or more on CTA.

Main reasons for not taking part

  • Needing blood pressure drugs, a breathing tube, or a lot of oxygen (FiO2 over 40% or over 6 LPM)
  • Severe high blood pressure in the lungs, CTEPH or CTED, or severe heart failure
  • Bleeding problems, low blood counts (hematocrit below 28%, platelets below 100,000/ML), or heparin cannot be given
  • Stroke or TIA in the last 90 days, or cancer needing chemotherapy
  • Pregnant or breastfeeding

The registry criteria, word for word

Show all 41 criteriaShow less

Who can take part

  • Subjects must meet all following general inclusion criteria:
  • Age ≥ 18 and ≤ 75 years
  • Clinical signs, symptoms, and presentation consistent with acute PE
  • PE symptom duration ≤ 14 days
  • CTA evidence (site determined) of proximal PE (filling defect in at least one main or interlobar pulmonary artery)
  • RV/LV ratio of ≥ 0.9 on CTA as assessed by investigator (site determined)
  • Systolic blood pressure ≥ 90 mmHg
  • Stable heart rate < 130 BPM prior to procedure
  • Patient is deemed medically eligible for interventional procedure(s), per institutional guidelines and clinical judgment
  • Informed Consent Form signed
  • Subject is willing and able to comply with all Clinical Investigation Plan required follow-up visit

Who cannot take part

  • Cardiovascular or pulmonary surgery within last 7 days
  • Known anaphylactic reaction to radiographic contrast agents that cannot be pretreated
  • Current participation in another investigational drug or device treatment study
  • Pulmonary hypertension with peak pulmonary artery pressure > 70 mmHg by right heart catheterization (site determined)
  • Actively progressing cancer requiring chemotherapy
  • Known bleeding diathesis or coagulation disorder
  • History of severe or chronic pulmonary arterial hypertension
  • History of uncompensated heart failure
  • History of underlying lung disease that is oxygen dependent
  • History of chest irradiation
  • History of heparin-induced thrombocytopenia (HIT)
  • History of Hemorrhagic or Ischemic Stroke, including Transient Ischemic Attack, within last 90 days
  • Current or history of chronic thromboembolic pulmonary hypertension (CTEPH) or chronic thromboembolic disease (CTED) diagnosis
  • Platelets < 100,000/ML
  • Serum creatinine > 1.8 mg/dL
  • International normalized ratio (INR) > 3
  • History of chronic left heart disease with left ventricular ejection fraction ≤ 30%
  • Subjects must not meet any of the following general exclusion criteria:
  • Thrombolytic use within 30 days of baseline CT angiogram
  • Vasopressor requirement after fluids to keep pressure ≥ 90 mmHg
  • FiO2 requirement > 40% or > 6 LPM to keep oxygen saturation > 90%
  • Hematocrit < 28%
  • Major trauma injury severity score (ISS) > 15 within the past 14 days
  • Presence of intracardiac lead in the right ventricle or right atrium placed within 6 months, Pacemaker or Implantable Cardioverter Defibrillators
  • Left bundle branch block
  • Patients who are under intubation
  • Any contraindication to systemic or therapeutic doses of heparin or anticoagulants
  • Imaging evidence or other evidence that suggests, in the opinion of the Investigator, the Subject is not appropriate for mechanical thrombectomy intervention
  • Life expectancy of < 90 days, as determined by Investigator
  • Female who is pregnant or nursing

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial is currently available in Poland.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vibrato™ Aspiration System for aspiration mechanical thrombectomy in the treatment of acute PE. This is the First in Man clinical study.

The group in the trial

  • Single arm studyTreatment being tested

    Vibrato™ Aspiration System for aspiration mechanical thrombectomy in the treatment of acute pulmonary embolism.

    Treatment: Mechanical Thrombectomy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Vibrato Aspiration System - Simple, Intuitive Approach to Clot Removal in Acute Pulmonary Embolism - a Safety & Feasibility Study
Plain-language title
Vibrato device for removing blood clots in sudden pulmonary embolismGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07685522, who can take part
Record updated
25 August 2026